Phakathi, Boitumelo http://orcid.org/0000-0002-8991-6060
Dix-Peek, Therese
Van Den Berg, Eunice
Dickens, Caroline
Nietz, Sarah
Cubasch, Herbert
Joffe, Maureen
Neugut, Alfred I.
Jacobson, Judith S.
Ruff, Paul
Duarte, Raquel
Funding for this research was provided by:
NIH/NCI grant (CA19262701)
R01 Grant (CA094061)
The South African Medical Research Council/University of the Witwatersrand Common Epithelial Cancer Research Center
The South African National Research Foundation major equipment grant (105646)
Prof Bongani Mayosi Clinical scholarship
University of KwaZulu-Natal
Article History
Received: 15 March 2023
Accepted: 3 May 2023
First Online: 2 June 2023
Declarations
:
: Dr Ruff has no conflicts of interest related to this study, but his institution receives funding for clinical trials from Roche, Pfizer, MSD, AstraZeneca, Jansen, Arcus, Novartis and Sanofi. Dr. Neugut has consulted for Otsuka, GlaxoSmithKline, United BioSource Corp, and Value Analytics, and serves on the medical advisory board of EHE Intl. Drs. Neugut and Jacobson receive grant funding from Otsuka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.